CCM
AZN icon

Coldstream Capital Management’s AstraZeneca AZN Stock Holding History

Coldstream Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
9,177
+603
+7% +$116K 0.02% 326
2025
Q4 		$1.58M Buy
8,574
+166
+2% +$29.1K 0.02% 343
2025
Q3 		$1.29M Sell
8,408
-48
-0.6% -$7.26K 0.02% 401
2025
Q2 		$1.18M Sell
8,456
-406
-5% -$56.9K 0.02% 382
2025
Q1 		$1.3M Sell
8,862
-3,541
-29% -$512K 0.03% 330
2024
Q4 		$1.63M Sell
12,403
-986
-7% -$138K 0.03% 284
2024
Q3 		$2.09M Buy
13,389
+525
+4% +$84.7K 0.05% 230
2024
Q2 		$2.01M Buy
12,864
+5,551
+76% +$835K 0.05% 202
2024
Q1 		$991K Buy
7,313
+1,640
+29% +$217K 0.03% 325
2023
Q4 		$764K Buy
5,673
+1,256
+28% +$163K 0.02% 360
2023
Q3 		$598K Buy
4,417
+428
+11% +$58.5K 0.02% 366
2023
Q2 		$571K Buy
3,989
+9
+0.2% +$1.32K 0.02% 400
2023
Q1 		$553K Buy
3,980
+33
+0.8% +$4.44K 0.02% 403
2022
Q4 		$535K Buy
+3,947
New +$495K 0.02% 408
2022
Q2 		$364K Buy
2,754
+753
+38% +$98.8K 0.01% 499
2022
Q1 		$265K Sell
2,001
-825
-29% -$98.9K 0.01% 622
2021
Q4 		$329K Buy
+2,826
New +$333K 0.01% 575

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Coldstream Capital Management's AZN Position: Q1 2026 in Review

Coldstream Capital Management increased its AstraZeneca (AZN) stake by 7% in Q1 2026, buying an estimated $116K and bringing the position to 9,177 shares worth $1.81M. The position accounts for 0.02% of the portfolio, ranked #326.

Coldstream Capital Management first reported a position in AZN in Q4 2021 and has held it in 17 quarters since. The position peaked at $2.09M in Q3 2024. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Coldstream Capital Management held 9,177 shares of AstraZeneca worth $1.81M as of Q1 2026.
  • Coldstream Capital Management bought 603 AstraZeneca shares in Q1 2026, an estimated $116K.
  • AstraZeneca made up 0.02% of Coldstream Capital Management's portfolio in Q1 2026, its #326 holding.
  • Coldstream Capital Management first reported a position in AstraZeneca in Q4 2021 and has held it in 17 quarters since.
  • Coldstream Capital Management's AstraZeneca position peaked at $2.09M in Q3 2024.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.